Amgen Recalls Anemia Drugs Due to Glass Flakes

By: Associated Press Email
By: Associated Press Email

THOUSAND OAKS, Calif. (AP) - Amgen Inc. is recalling some lots of its Epogen and Procrit anemia treatments because they may contain glass flakes.

The Thousand Oaks, Calif., biotechnology company says the flakes are barely visible in most cases, and they have fielded no complaints or reports about problems that can be directly tied to them.

Amgen says the flakes are caused by the interaction of the drug with glass vials over the product's shelf life.

The affected lot numbers and expiration dates can be found on Web sites for the products.

Epogen treats anemia in patients with chronic renal failure who are on dialysis. Procrit also treats it for cancer patients on chemotherapy and some HIV-infected patients.


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
KOLO-TV 4850 Ampere Drive Reno, NV 89502
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 103710089 - kolotv.com/a?a=103710089
Gray Television, Inc.